1. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial… [603700]

1. American Thoracic Society/European Respiratory Society. International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 2. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P. et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007; 3. Bouros D, Antoniou K M. Current and future therapeutic approaches in idiopathic pulmonary fibrosis; 4. Bridges JP, Xu Y, Na CL, Wong HR, Weaver TE. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol. 2006; 5. Bullard JE, Wert SE, Nogee LM. ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. Semin Perinatol. 2006; 6. Bush A, Cunningham S, de Blic J, Barbato A, Clement A, Epaud R, Hengst M, Kiper N, Nicholson AG, Wetzke M, Snijders D, Schwerk N, Griese M (November 2015). 7. Castillo M, Vade A, Lim-Dunham JE, Masuda E, Massarani-Wafai R. Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation.Pediatr Radiol. 2010; 8. Cheon CK, Jin HS, Kang EK, et al. Epidemic acute interstitial pneumonia in children occurred during the early 2006s. Korean J Pediatr. 2008; 9. Chernick J, Mellins RB Thurlbeck WM (1991) Pre- and postnatal organ development. in Basic mechanisms of respiratory disease: Cellular and integrative. eds Chernick J, Mellins RB 10. Clement A, Eber E. Interstitial lung diseases in infants and children. Eur Respir J. 2008; 11. Clement A. and committee members. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004 12. de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E. et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J. 2000; 13. Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 2002; 14. Fan LL, Deterding RR, Langston C. Pediatric interstitial lung

15. Fan LL, Lung MC, Wagener JS. The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates. Pediatr Pulmonol. 1997; 16. Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr2004; 17. Gilbert C, Bush A, Cunningham S. Childhood interstitial lung disease: family experiences. Pediatr Pulmonol. 2015; 18. Griese M, Irnstetter A, Hengst M, Burmester H, Nagel F, Ripper J, Feilcke M, Pawlita I, Gothe F, Kappler M, Schams A, Wesselak T, Rauch D, Wittmann T, Lohse P, Brasch F, Kröner C (September 2015) 19. Kim KK, Chapman HA. Endothelin-1 as initiator of epithelial-mesenchymal transition: potential new role for endothelin-1 during pulmonary fibrosis. Am J Respir Cell Mol Biol. 2007; 20. Kim KW, Ahn K, Yang HJ, et al. Humidifier disinfectant-associated children’s interstitial lung disease. Am J Respir Crit Care Med. 2014; 21. Kodama Y, Tao K, Ishida F, et al. Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan. Pediatr Int. 2012; 22. Komi-Kuramochi A, Kawano M, Oda Y, et al. Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol 2005; 23. Krude H, Schütz B, Biebermann H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest. 2002; 24. Kuwano K, Hagimoto N, Tanaka T, et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 2000; 25. Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis. Rheumatology; 26. Lenney W, Boner AL, Bont L, et al. Medicines; 27. Lord A, Shapiro AJ, Saint-Martin C, Claveau M, Melançon S, Wintermark P. Filamin A mutation may be associated with diffuse lung disease mimicking bronchopulmonary dysplasia in premature newborns. Respir Care. 2014 28. Martin W J, Iannuzzi M C, Gail D B. et al Future directions in sarcoidosis research;

29. Midulla F, Strappini PM, Ascoli V, Villa MP, Indinnimeo L, Falasca C. et al. Bronchoalveolar lavage cell analysis in a child with chronic lipid pneumonia. Eur Respir J. 1998; 30. Morgenthau AS, Padilla ML. Mt Sinai J Med. 2009; 31. Nicolaou N, Margadant C, Kevelam SH, et al. Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest. 2012; 32. Nobuhara KK, Fauza DO, DiFiore JW, et al. (1998) Continuous intrapulmonary distension with perfluorocarbon accelerates neonatal (but not adult) lung growth. J Ped Surg; 33. Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 2001; 34. Orlandi A, Francesconi A, Marcellini M, Ferlosio A, Spagnoli LG. Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit. Cardiovasc Res. 2004;64(3):544–52. doi: 10.1016/j.cardiores.2004 35. Owens C. Radiology of diffuse interstitial pulmonary disease in children. Eur Radiol. 2004 36. Picard C, Thouvenin G, Kannengiesser C, et al. Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation). Chest 2016; 37. Price A, Manson D, Cutz E, Dell S. Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF. Pediatr Pulmonol 2006; 38. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer. 2004; 39. Rama JA, Fan LL, Faro A, et al. Lung transplantation for childhood diffuse lung disease. Pediatr Pulmonol. 2013; 40. Respiratory diseases only seen in children. Eur Respir J. 2009; 41. Rosen DM, Waltz DA. Hydroxychloroquine and surfactant protein C deficiency. N Engl J Med. 2005 42. Schock F, Perrimon N. Molecular mechanisms of epithelial morphogenesis. Annu Rev Cell Dev Biol. 2002; 43. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res2002

44. Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med2001; 45. Swigris J J, Berry G J, Raffin T A. et al Lymphoid interstitial pneumonia; 46. UNAIDS. AIDS epidemic update, http://www.unaids.org; 2007 47. Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J. et al. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Scand J Immunol. 2009; 48. Warburton D, Perin L, Defilippo R, Bellusci S, Shi W, Driscoll B. Stem/progenitor cells in lung development, injury repair, and regeneration. Proc Am Thorac Soc. 2008; 49. Whelan TP (March 2012). "Lung transplantation for interstitial lung disease". Clinics in Chest Medicine. 50. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 51. Young LR, Deutsch GH, Bokulic RE, et al. A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy. Chest 2013; 52. Young LR, Nogee LM, Barnett B, Panos RJ, Colby TV, Deutsch GH. Usual interstitial pneumonia in an adolescent with ABCA3 mutations. Chest. 2008;